W.R. Huff Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BIT
BFA
W.R. Huff Asset Management's BMY Position: Q4 2016 in Review
W.R. Huff Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.02% in Q4 2016, selling an estimated $273 and leaving 25,995 shares worth $1.52M. The position accounts for 1.31% of the portfolio, ranked #27.
W.R. Huff Asset Management first reported a position in BMY in Q4 2014 and has held it in 9 quarters since. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.
- W.R. Huff Asset Management held 25,995 shares of Bristol-Myers Squibb worth $1.52M as of Q4 2016.
- W.R. Huff Asset Management sold 5 Bristol-Myers Squibb shares in Q4 2016, an estimated $273.
- Bristol-Myers Squibb made up 1.31% of W.R. Huff Asset Management's portfolio in Q4 2016, its #27 holding.
- W.R. Huff Asset Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 9 quarters since.
- 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.
Based on W.R. Huff Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.